By Connor Hart
Hinge Health has filed for an initial public offering with the Securities and Exchange Commission.
The San Francisco-based company, which leverages software and artificial intelligence to largely automate care for joint and muscle health, didn't say Monday how many shares it would list or give an anticipated price range. It plans to list shares on the New York Stock Exchange under the ticker HNGE.
The company reported a loss of $11.9 million on revenue of $390.4 million in 2024. A year earlier, it notched a loss of $108 million on sales of $292.7 million.
Hinge Health didn't say how much in proceeds it expects from the offering. The company intends to use a portion of proceeds to satisfy tax withholding and remittance obligations related to a settlement involving restricted stock units, as well as for general corporate purposes, working capital and to fund growth strategies and initiatives.
Morgan Stanley, Barclays Capital and BofA Securities, are listed as the offering's underwriting partners.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
March 10, 2025 17:16 ET (21:16 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.